“…Hence, clinical outcomes of patients with chronic HF are now significantly better, but patients with severe chronic HF who do not respond well to standard drug therapies still have poor outcomes. 1 In addition, although patients with end-stage severe HF benefit from heart transplantation or left ventricular assist system (LVAS) implantation, 2 these procedures are indicated for only a limited number of such patients worldwide where the number of heart 992 SAWA Y et al…”
“…Hence, clinical outcomes of patients with chronic HF are now significantly better, but patients with severe chronic HF who do not respond well to standard drug therapies still have poor outcomes. 1 In addition, although patients with end-stage severe HF benefit from heart transplantation or left ventricular assist system (LVAS) implantation, 2 these procedures are indicated for only a limited number of such patients worldwide where the number of heart 992 SAWA Y et al…”
“…All patients accomplished CPXT without any complication (maximal load, 75±35 W). The expiratory change ratio was 1.3±0.2 (range 1.1-1.6), and the Borg scale was 18±2 points (range [17][18][19][20].…”
“…7) It is no wonder that patients dependent on inotrope infusion soon receive VAD therapy, but more surprisingly survival rates of those who are listed but ambulatory (4-year survival rate, 68%) are similar to the patients once dependent inotrope (4-year survival rate, 65%). This strongly suggests the powerful ability to save life by VAD therapy.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.